News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
364,489 Results
Type
Article (14474)
Company Profile (114)
Press Release (349901)
Section
Business (112713)
Career Advice (456)
Deals (18627)
Drug Delivery (28)
Drug Development (31221)
Employer Resources (50)
FDA (8800)
Job Trends (7678)
News (172911)
Policy (12376)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1320)
Allergies (39)
Alliances (34791)
ALS (22)
Alzheimer's disease (506)
Antibody-drug conjugate (ADC) (62)
Approvals (8819)
Artificial intelligence (227)
Autoimmune disease (2)
Automation (11)
Bankruptcy (132)
Best Places to Work (6522)
BIOSECURE Act (6)
Biosimilars (9)
Biotechnology (86)
Bladder cancer (21)
Brain cancer (11)
Breast cancer (109)
Cancer (952)
Cardiovascular disease (60)
Career advice (406)
Career pathing (8)
CAR-T (97)
Cell therapy (256)
Cervical cancer (10)
Clinical research (24468)
Collaboration (566)
Compensation (103)
Complete response letters (3)
COVID-19 (1146)
CRISPR (34)
C-suite (131)
Cystic fibrosis (47)
Data (913)
Decentralized trials (1)
Denatured (18)
Depression (16)
Diabetes (93)
Diagnostics (4899)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (73)
Drug pricing (13)
Drug shortages (4)
Duchenne muscular dystrophy (19)
Earnings (38616)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51216)
Executive appointments (366)
FDA (9374)
Featured Employer (25)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (447)
Gene editing (80)
Generative AI (23)
Gene therapy (161)
GLP-1 (223)
Government (1233)
Grass and pollen (2)
Guidances (23)
Healthcare (9901)
Huntington's disease (5)
IgA nephropathy (10)
Immunology and inflammation (28)
Indications (11)
Infectious disease (1217)
Inflammatory bowel disease (60)
Inflation Reduction Act (3)
Influenza (31)
Intellectual property (57)
Interviews (51)
IPO (8004)
IRA (8)
Job creations (1440)
Job search strategy (362)
Kidney cancer (3)
Labor market (9)
Layoffs (116)
Leadership (3)
Legal (2524)
Liver cancer (34)
Lung cancer (121)
Lymphoma (56)
Machine learning (2)
Management (17)
Manufacturing (167)
MASH (15)
Medical device (11455)
Medtech (11460)
Mergers & acquisitions (10948)
Metabolic disorders (201)
Multiple sclerosis (25)
NASH (3)
Neurodegenerative disease (27)
Neuropsychiatric disorders (3)
Neuroscience (685)
NextGen: Class of 2025 (3536)
Non-profit (1520)
Northern California (1028)
Now hiring (8)
Obesity (86)
Opinion (75)
Ovarian cancer (39)
Pain (46)
Pancreatic cancer (38)
Parkinson's disease (63)
Partnered (11)
Patents (129)
Patient recruitment (48)
Peanut (26)
People (32699)
Pharmaceutical (16)
Phase I (9016)
Phase II (11042)
Phase III (7171)
Pipeline (498)
Podcasts (37)
Policy (27)
Postmarket research (505)
Preclinical (4069)
Press Release (66)
Prostate cancer (39)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (131)
Real estate (3365)
Recruiting (20)
Regulatory (9347)
Reports (18)
Research institute (1270)
Resumes & cover letters (68)
Rett syndrome (2)
RNA editing (2)
RSV (21)
Schizophrenia (11)
Series A (81)
Series B (48)
Service/supplier (7)
Sickle cell disease (18)
Southern California (1117)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2505)
State (2)
Stomach cancer (2)
Supply chain (22)
The Weekly (18)
United States (10833)
Vaccines (309)
Venture capitalists (19)
Webinars (7)
Weight loss (34)
Women's health (17)
Worklife (2)
Date
Today (77)
Last 7 days (339)
Last 30 days (1396)
Last 365 days (17689)
2025 (4243)
2024 (18733)
2023 (22110)
2022 (30818)
2021 (32519)
2020 (30546)
2019 (25813)
2018 (19466)
2017 (18892)
2016 (17781)
2015 (20597)
2014 (15197)
2013 (12759)
2012 (13814)
2011 (14101)
2010 (12866)
Location
Africa (318)
Alabama (37)
Alaska (6)
Arizona (119)
Arkansas (10)
Asia (24007)
Australia (4180)
California (2690)
Canada (984)
China (228)
Colorado (154)
Connecticut (126)
Delaware (39)
Europe (49105)
Florida (443)
Georgia (131)
Idaho (33)
Illinois (265)
India (10)
Indiana (152)
Iowa (4)
Japan (100)
Kansas (80)
Kentucky (6)
Louisiana (5)
Maine (20)
Maryland (432)
Massachusetts (1894)
Michigan (179)
Minnesota (240)
Mississippi (2)
Missouri (57)
Montana (24)
Nebraska (15)
Nevada (19)
New Hampshire (66)
New Jersey (851)
New Mexico (16)
New York (806)
North Carolina (505)
North Dakota (7)
Northern California (1028)
Ohio (99)
Oklahoma (11)
Oregon (19)
Pennsylvania (553)
Puerto Rico (7)
Rhode Island (20)
South America (506)
South Carolina (16)
South Dakota (1)
Southern California (1117)
Tennessee (55)
Texas (437)
Utah (99)
Virginia (53)
Washington D.C. (11)
Washington State (312)
West Virginia (3)
Wisconsin (35)
364,489 Results for "valencia technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Valencia Technologies Appoints Richard W. Klauer as Vice President of Sales
March 3, 2025
·
2 min read
Press Releases
Valencia Technologies Announces Strategic Investment of up to $35 Million and Appointment of James D. Surek as Chief Executive Officer
February 20, 2025
·
4 min read
Biotech Beach
Cover the Latest Developments in Allergy and Clinical Immunology at the EAACI Congress 2024 in Valencia, Spain
The European Academy of Allergy and Clinical Immunology, with a membership of over 16,000 from 125 countries, annually orchestrates its congress to unveil the latest research and innovative advancements in allergy and clinical immunology.
March 19, 2024
·
2 min read
Business
Valencia Technologies Retains PRIA Healthcare to Improve Patient Access to the eCoin for treatment of Urge Urinary Incontinence (UUI)
Valencia Technologies Corporation (" Valencia " or the “Company”), a privately held company, today announced it has retained PRIA Healthcare to assist in patient access for Valencia’s recently FDA approved proprietary product, eCoin®.
May 11, 2022
·
3 min read
Biotech Beach
Valencia Technologies Announces First Commercial Implantation of eCoin® Leadless Tibial Neurostimulator for the Treatment of Urge Urinary Incontinence
Valencia Technologies Corporation, a privately held company, today announced that it has completed the world’s first commercial implantation of eCoin® in Sarasota, FL.
June 6, 2022
·
3 min read
Business
Valencia Technologies Strengthens Leadership Team with Key Appointments
Valencia Technologies, a privately held company, today announced the expansion of its leadership team with the appointments of Jerry Schloffman as Chief Commercial Officer, Jim Crines as Interim Chief Financial Officer, Arthur Rascon as Senior Vice President of Operations, and Ann Decker as Vice President of Reimbursement.
November 29, 2021
·
5 min read
FDA
Valencia Technologies Announces FDA Approval of eCoin® Therapy to Treat Urinary Urge Incontinence
Valencia Technologies Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) of its eCoin ® leadless tibial neurostimulator for the treatment of urinary incontinence (UUI), which affects over 60% of patients who suffer from Overactive Bladder (OAB).
March 2, 2022
·
5 min read
Genetown
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
Astria Therapeutics, Inc. today announced that it will present two posters at the upcoming European Academy of Allergy and Clinical Immunology (EAACI) Congress in Valencia, Spain on June 1, 2024.
May 23, 2024
·
1 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Bio NC
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunology
BioCryst Pharmaceuticals Inc. announced that new data on oral, once-daily ORLADEYO® for the prophylactic treatment of hereditary angioedema will be presented at the European Academy of Allergy and Clinical Immunology meeting in Valencia, Spain from May 31 to June 3, 2024.
May 14, 2024
·
5 min read
1 of 36,449
Next
